ModernMedicine Resource Center More Topics
 

Biologic treatments for moderate-to-severe atopic dermatitis

Appreciating the role of microbial communities on the skinMicrobial colonization in the development of inflammatory conditions and immune-mediated conditions is a hot research topic, and new dermatologic therapies can potentially result from greater understanding of the role of microbial communities on the skin and in the gut.
Pattern distinguishes atopic, contact dermatitisPart of the management of contact dermatitis is identifying the offending agent through patch testing and eliminating contact with the offending agent.
Investigative eczema drug shows positive phase 2 resultsUK-based Ziarco Pharma Ltd. recently announced positive phase 2a results for ZPL-389, a once daily oral histamine H4 receptor antagonist, for the treatment of moderate to severe atopic dermatitis.
Dupilumab demonstrates promising resultsThe systemic therapy dupilumab met primary endpoints in two phase 3 studies on adults with in inadequately controlled moderate-to-severe atopic dermatitis.
Merger to boost eczema offeringsPfizer and Anacor Pharmaceuticals announced in May that the pharmaceutical companies merged with Pfizer acquiring Anacor for about $5.2 billion. Dermatologists say merger is a good move for patients.
Oatmeal soothes, relieves, and inhibits viruses
Oatmeal soothes, relieves, and inhibits virusesGood for more than a morning meal, oatmeal soothes angry skin, relieves itching, and even has an antimicrobial effect.
  • 1
  • 2